Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ELOX: Eloxx Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ELOX
The Story
ELOX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
66.2%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
-9.8×
Current ratio
0.48×
Eloxx Pharmaceuticals, Inc.
ELOX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Eloxx Pharmaceuticals, Inc.
ELOX
NASDAQ
·
USD
·
Closed
$17.43
+31.05%
$17.43
+$4.13 (31.05%)
52W Range
90th
pctl
Volume
0.77×
avg
Mkt Cap
132.00M
USD
P/E
-3.0
TTM
Div Yield
–
ann
52W Range
90th
pctl
Volume
0.77×
avg
Market Cap
132.00M
USD
P/E Ratio
-3.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings